Literature DB >> 28034873

An incomplete trafficking defect to the cell-surface leads to paradoxical thrombocytosis for human and murine MPL P106L.

Fabrizia Favale1,2,3,4, Kahia Messaoudi1,2,3, Leila N Varghese5,6, Siham Boukour1,2,3, Christian Pecquet5,6, Vitalina Gryshkova5,6, Jean Philippe Defour5,6, Roxana-Irina Albu5,6, Olivier Bluteau1,2,3, Paola Ballerini7, Guy Leverger7, Isabelle Plo1,2,3, Najet Debili1,2,3, Hana Raslova1,2,3, Remi Favier1,2,3,7, Stefan N Constantinescu5,6, William Vainchenker1,2,3.   

Abstract

The mechanisms behind the hereditary thrombocytosis induced by the thrombopoietin (THPO) receptor MPL P106L mutant remain unknown. A complete trafficking defect to the cell surface has been reported, suggesting either weak constitutive activity or nonconventional THPO-dependent mechanisms. Here, we report that the thrombocytosis phenotype induced by MPL P106L belongs to the paradoxical group, where low MPL levels on platelets and mature megakaryocytes (MKs) lead to high serum THPO levels, whereas weak but not absent MPL cell-surface localization in earlier MK progenitors allows response to THPO by signaling and amplification of the platelet lineage. MK progenitors from patients showed no spontaneous growth and responded to THPO, and MKs expressed MPL on their cell surface at low levels, whereas their platelets did not respond to THPO. Transduction of MPL P106L in CD34+ cells showed that this receptor was more efficiently localized at the cell surface on immature than on mature MKs, explaining a proliferative response to THPO of immature cells and a defect in THPO clearance in mature cells. In a retroviral mouse model performed in Mpl-/- mice, MPL P106L could induce a thrombocytosis phenotype with high circulating THPO levels. Furthermore, we could select THPO-dependent cell lines with more cell-surface MPL P106L localization that was detected by flow cytometry and [125I]-THPO binding. Altogether, these results demonstrate that MPL P106L is a receptor with an incomplete defect in trafficking, which induces a low but not absent localization of the receptor on cell surface and a response to THPO in immature MK cells.
© 2016 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28034873     DOI: 10.1182/blood-2016-06-722058

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

Review 1.  In and out: Traffic and dynamics of thrombopoietin receptor.

Authors:  Anita Roy; Saurabh Shrivastva; Saadia Naseer
Journal:  J Cell Mol Med       Date:  2021-08-27       Impact factor: 5.295

Review 2.  Genetic Alterations of the Thrombopoietin/MPL/JAK2 Axis Impacting Megakaryopoiesis.

Authors:  Isabelle Plo; Christine Bellanné-Chantelot; Matthieu Mosca; Stefania Mazzi; Caroline Marty; William Vainchenker
Journal:  Front Endocrinol (Lausanne)       Date:  2017-09-12       Impact factor: 5.555

Review 3.  The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated Calreticulin.

Authors:  Leila N Varghese; Jean-Philippe Defour; Christian Pecquet; Stefan N Constantinescu
Journal:  Front Endocrinol (Lausanne)       Date:  2017-03-31       Impact factor: 5.555

4.  Identification of MPL R102P Mutation in Hereditary Thrombocytosis.

Authors:  Christine Bellanné-Chantelot; Matthieu Mosca; Caroline Marty; Rémi Favier; William Vainchenker; Isabelle Plo
Journal:  Front Endocrinol (Lausanne)       Date:  2017-09-20       Impact factor: 5.555

5.  Thrombopoietin is required for full phenotype expression in a JAK2V617F transgenic mouse model of polycythemia vera.

Authors:  Jerry L Spivak; Akil Merchant; Donna M Williams; Ophelia Rogers; Wanke Zhao; Amy Duffield; Linda S Resar; Alison R Moliterno; Zhizhuang J Zhao
Journal:  PLoS One       Date:  2020-06-01       Impact factor: 3.752

6.  C-Cbl regulates c-MPL receptor trafficking and its internalization.

Authors:  Melanie Märklin; Claudia Tandler; Hans-Georg Kopp; Kyle L Hoehn; Leticia Quintanilla-Martinez; Oliver Borst; Martin R Müller; Sebastian J Saur
Journal:  J Cell Mol Med       Date:  2020-09-20       Impact factor: 5.310

Review 7.  Functional Consequences of Mutations in Myeloproliferative Neoplasms.

Authors:  Stefan N Constantinescu; William Vainchenker; Gabriel Levy; Nicolas Papadopoulos
Journal:  Hemasphere       Date:  2021-06-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.